EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS193-30449 
Organism
Homo sapiens 
Tissue/cell
U87 
Coordinate
chr6:112144890-112145750 
Number of super-enhancer constituents: 11             
IDCoordinateTissue/cell
SE_11818chr6:112144554-112146266CD3
SE_17365chr6:112144336-112149084CD4p_CD25-_CD45RAp_Naive
SE_17771chr6:112143917-112148365CD4p_CD25-_CD45ROp_Memory
SE_18241chr6:112143845-112149691CD4p_CD25-_Il17-_PMAstim_Th
SE_19116chr6:112143913-112147375CD4p_CD25-_Il17p_PMAstim_Th17
SE_19973chr6:112143849-112147183CD56
SE_22283chr6:112143698-112147483CD8_primiary
SE_30347chr6:112143831-112146132Fetal_Muscle
SE_37268chr6:112143741-112146622HSMMtube
SE_46582chr6:112143862-112147349Osteoblasts
SE_62227chr6:112031022-112196404Tonsil
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr6112145008112145393
Number: 1             
IDChromosomeStartEnd
GH06I111822chr6112143966112147543
Enhancer Sequence
AATCCAAGCT CTTGTATCAT GCTAACATAA CAGATCTCAG CTAACTATTA CAAGTGTTAA 60
AATATGTGTC TGGGTGGGAA GCCCAAATTA ACTGGTCATT TTGAAAAGGA AGCCATGAGG 120
AAGGACAAAA CATTCTCACA GAATATATAT AAACACTCAC ATTGACTTTC AGTTTATCAA 180
ATTTCCTGAG GAAAGAAGTT CCCATTTGTA GCTGACGTAT ATTGTAACAA CACACCCAAC 240
CATTTCATTA GAATGCTATT TTTAATCAGT TCGGCATACA TTATGCCTCA GGAACTGAAA 300
GCAAGGAGTA CATAAAGTCA TCAGCTGTGG ATATAGAATA CTCAGAAGTC AAATAACATT 360
TCAAACTGGG CAAATAGCTT AAAAAGCATA GCAACTCTAC AAAGGAAAAG TTTCAACTGC 420
TCTTCTGTGA GCACATGGTC TTTAAAAAAT CCCCACTGCA AACTTTGGAA AGTTGAAAAA 480
CATCTTTTGC AAGATGTGAA GAATGCATTT GGTAATGACT CACTTGTGAT AACATCACTG 540
GGTGGGCCAC TGCCACAGAA TCTATCCTAA GCTCATTTCA CTCTGCTCTG GTCTCTTCAT 600
AGTCTATTAA GGGGCAACGT GGATGATGGT AAATATTAGT GCCTCTACTT TGAAATGATT 660
TTCCTCCCAA GGTAACTAAT ACATTCTCAG GCATGTGGAA AAAGAACTCA TGCAAAAGCT 720
CCCTGTATAC TAGACTTAAC TTTCTCCTGA AATTTAGGAG AAAGCCTTGA CACCATCATG 780
GATGAGAGAA ATCTACACTG CATCTTGTTA ACATCAGATG ATGTTGTTGC CCATGACTCT 840
GTACCTTTGT CTATCTATAG 860